These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18451011)

  • 1. What CATIE did: some thoughts on implications deep and wide.
    Owens DC
    Psychiatr Serv; 2008 May; 59(5):530-3. PubMed ID: 18451011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
    Berkowitz RL; Patel U; Ni Q; Parks JJ; Docherty JP
    J Clin Psychiatry; 2012 Apr; 73(4):498-503. PubMed ID: 22226332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First- and second-generation antipsychotics: learning from CUtLASS and CATIE.
    Tandon R; Carpenter WT; Davis JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):977-8; author reply 979-80. PubMed ID: 17679642
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE).
    Lieberman JA
    Arch Gen Psychiatry; 2006 Oct; 63(10):1069-72. PubMed ID: 17015808
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine.
    Kapur S; Roy P; Daskalakis J; Remington G; Zipursky R
    Am J Psychiatry; 2001 Feb; 158(2):311-4. PubMed ID: 11156818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are second generation antipsychotics a distinct class?
    Bonham C; Abbott C
    J Psychiatr Pract; 2008 Jul; 14(4):225-31. PubMed ID: 18664891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D
    N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of clozapine versus other antipsychotics on clinical outcome and dopamine release in the brain.
    Advokat C
    Essent Psychopharmacol; 2005; 6(2):73-90. PubMed ID: 15765792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia.
    Hummer M; Kemmler G; Kurz M; Kurzthaler I; Oberbauer H; Fleischhacker WW
    Am J Psychiatry; 1999 Apr; 156(4):631-3. PubMed ID: 10200746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics, tardive dyskinesia, and D(2) receptors.
    Duggal HS; Mendhekar DN
    Am J Psychiatry; 2006 Aug; 163(8):1449-50. PubMed ID: 16877664
    [No Abstract]   [Full Text] [Related]  

  • 13. [Expectations and developments in atypical antipsychotics].
    Praxis (Bern 1994); 2004 Aug; 93(35):1392. PubMed ID: 15468579
    [No Abstract]   [Full Text] [Related]  

  • 14. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic medication for childhood-onset schizophrenia.
    Kennedy E; Kumar A; Datta SS
    Schizophr Bull; 2007 Sep; 33(5):1082-3. PubMed ID: 17670793
    [No Abstract]   [Full Text] [Related]  

  • 16. Schizophrenia: recent advances in psychopharmacology.
    Sharma T
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):194-8. PubMed ID: 8777500
    [No Abstract]   [Full Text] [Related]  

  • 17. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
    Cipriani A; Accordini S; Nosè M; Purgato M; Girlanda F; Tansella M; Barbui C
    J Clin Psychopharmacol; 2013 Aug; 33(4):533-7. PubMed ID: 23775051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to the CATIE special section.
    Swartz MS
    Psychiatr Serv; 2008 May; 59(5):497-9. PubMed ID: 18451004
    [No Abstract]   [Full Text] [Related]  

  • 20. Clozapine: more side effects but still the best antipsychotic.
    Kang X; Simpson GM
    J Clin Psychiatry; 2010 Aug; 71(8):982-3. PubMed ID: 20797378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.